Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1439400-05-1

C23H25FN6O5S2 is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1439400-05-1 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 1439400-05-1 Structure

  • Basic information

    1. Product Name: C23H25FN6O5S2
    2. Synonyms: C23H25FN6O5S2
    3. CAS NO:1439400-05-1
    4. Molecular Formula:
    5. Molecular Weight: 548.619
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 1439400-05-1.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: N/A
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: C23H25FN6O5S2(CAS DataBase Reference)
    10. NIST Chemistry Reference: C23H25FN6O5S2(1439400-05-1)
    11. EPA Substance Registry System: C23H25FN6O5S2(1439400-05-1)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 1439400-05-1(Hazardous Substances Data)

1439400-05-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1439400-05-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,4,3,9,4,0 and 0 respectively; the second part has 2 digits, 0 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1439400-05:
(9*1)+(8*4)+(7*3)+(6*9)+(5*4)+(4*0)+(3*0)+(2*0)+(1*5)=141
141 % 10 = 1
So 1439400-05-1 is a valid CAS Registry Number.

1439400-05-1Downstream Products

1439400-05-1Relevant articles and documents

HETEROCYCLIC INHIBITORS OF GLUTAMINASE

-

Page/Page column 65; 66, (2013/06/06)

The invention relates to the heterocyclic compounds of Formula (I) as defined further herein, and pharmaceutical preparations thereof. The invention further relates to methods of treating cancer, immunological or neurological diseases using the heterocyclic compounds of the invention.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1439400-05-1